Ratings for Hims & Hers Health HIMS were provided by 12 analysts in the past three months, showcasing a mix of bullish and ...

Ratings for Hims & Hers Health (NYSE:HIMS) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of ...

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $25.41 which represents a decrease of $-0.32 or -1.24% from the prior close of $25.73. The stock opened at $24.15 and touched a low ...

While Hims offers more options for sexual health and hair loss, Roman offers more options overall. Here’s our full breakdown of Hims vs. Roman for erectile dysfunction, hair loss, and more.